Phase II study of cladribine, idarubicin, and ara‐C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia.

Details

Language :

English

ISSN :

03618609

Volume :

98

Issue :

11

Database :

Complementary Index

Journal :

American Journal of Hematology

Publication Type :

Academic Journal

Accession number :

172913330

Full Text :

https://doi.org/10.1002/ajh.27054